Dr. Saltz Discusses FOLFIRINOX in Colorectal Cancer
January 17th 2018Leonard Saltz, MD, executive director for Clinical Value & Sustainability, head, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center, discusses the option of FOLFIRINOX for the treatment of patients with metastatic colorectal cancer.
Read More